Chinese Academy of Medical Science and Blood Disease Hospital
Chinese Academy of Medical Science and Blood Disease Hospital
Tianjin, China5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Bometase Alfa for Bleeding Control in Acquired Hemophilia A | acquired hemophilia A | Not yet recruiting | Not applicable | 2026-08-27 | NCT07789587 | |
| A Study of Elranatamab for Inhibitor Eradication in Patients With Hemophilia A | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Not yet recruiting | Not applicable | 2026-08-26 | NCT07788469 | |
| Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP) | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Recruiting | Phase 2 | 2026-01-23 | NCT07362238 | |
| An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia A | acquired hemophilia | Recruiting | Phase 4 | 2025-08-05 | NCT05849740 | |
| A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP | Herombopag | Recruiting | Phase 2 | 2025-03-13 | NCT06838949 |